IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 147 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $537,332 | +308.5% | 193,285 | +167.5% | 0.00% | – |
Q1 2023 | $131,524 | -97.1% | 72,266 | -91.9% | 0.00% | -100.0% |
Q4 2022 | $4,547,593 | +1810.8% | 896,961 | +1772.3% | 0.01% | +1100.0% |
Q3 2022 | $238,000 | -1.7% | 47,907 | -26.2% | 0.00% | 0.0% |
Q2 2022 | $242,000 | – | 64,945 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |